In the last few years, molecular imaging with PSMA positron emission tomography/computed tomography (PET/CT) has emerged as a useful tool complementing mpMRI’s role in the initial staging of PCa, along its proven capability to better display recurrent and metastatic lesions [18]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.